ANDROXAL Trademark

Trademark Overview

On Tuesday, January 3, 2006, a trademark application was filed for ANDROXAL with the United States Patent and Trademark Office. The USPTO has given the ANDROXAL trademark a serial number of 78783879. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 13, 2018. This trademark is owned by Zonagen, Inc.. The ANDROXAL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of hypogonadism and wasting disease in AIDS patients
androxal

General Information

Serial Number78783879
Word MarkANDROXAL
Filing DateTuesday, January 3, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 13, 2018
Registration Number3353823
Registration DateTuesday, December 11, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2006

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of hypogonadism and wasting disease in AIDS patients

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 13, 2018
Primary Code005
First Use Anywhere DateMonday, April 4, 2005
First Use In Commerce DateTuesday, January 2, 2007

Trademark Owner History

Party NameREPROS THERAPEUTICS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTHE WOODLANDS, TX 77380
Party NameREPROS THERAPEUTICS INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressTHE WOODLANDS, TX 77380
Party NameZonagen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThe Woodlands, TX 77380
Party NameZonagen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThe Woodlands, TX 77380

Trademark Events

Event DateEvent Description
Friday, July 13, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, December 11, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 19, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, December 19, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, December 10, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, December 19, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 10, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, December 11, 2007REGISTERED-PRINCIPAL REGISTER
Wednesday, November 7, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, November 7, 2007ASSIGNED TO LIE
Tuesday, October 9, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 14, 2007ASSIGNED TO EXAMINER
Wednesday, September 12, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, August 10, 2007STATEMENT OF USE PROCESSING COMPLETE
Sunday, August 5, 2007USE AMENDMENT FILED
Wednesday, September 5, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, March 6, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 12, 2006PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2006NOTICE OF PUBLICATION
Thursday, October 19, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 18, 2006ASSIGNED TO LIE
Wednesday, October 11, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 10, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 14, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 14, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 25, 2006NON-FINAL ACTION E-MAILED
Sunday, June 25, 2006NON-FINAL ACTION WRITTEN
Saturday, June 24, 2006ASSIGNED TO EXAMINER
Monday, January 9, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

androxal disease aids patients wasting hypogonadism preparations treatment pharmaceutical